Global Surgical Sutures Market Report and Forecast 2023-2031

Abstract
Global Surgical Sutures Market Report and Forecast 2023-2031
Global Surgical Sutures Market Outlook
The global surgical sutures market value was USD 4 billion in 2022, driven by the increasing number of surgical procedures across the globe. The market size is anticipated to grow at a CAGR of 6% during the forecast period of 2023-2031 to achieve a value of USD 6.8 billion by 2031.

Surgical Sutures Introduction
Surgical sutures, also known as stitches, are medical devices used to close wounds or surgical incisions by holding tissues together until the healing process is complete. They are commonly made from materials such as natural fibres (e.g., silk or catgut) or synthetic materials (e.g., polypropylene or nylon) and are available in various types, such as absorbable or non-absorbable sutures, and different thread sizes and needle shapes. The choice of suture depends on factors such as the type of tissue, the desired healing time, and the surgeon's preference.
Surgical Sutures Market Scenario
The global surgical sutures market has experienced significant growth in recent years, driven by factors such as the increasing number of surgical procedures, an aging global population, and advancements in suture materials and technologies. Furthermore, the growing demand for minimally invasive surgical procedures and rising awareness about the importance of proper wound management have contributed to the market's expansion.
North America: The largest market for surgical sutures, driven by factors such as the advanced healthcare infrastructure, a high number of surgical procedures, and the presence of major surgical suture manufacturers.
Europe: The second-largest market, with increasing demand for surgical sutures due to a growing aging population and a supportive regulatory framework.
Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Surgical Sutures Market Segments
Market Breakup by Product Type
•Absorbable
Synthetic Suture
Polyglactin 910 Sutures
Poliglecaprone 25 Sutures
Polydioxanone Sutures
Polyglycolic Acid Sutures
Other Synthetic Sutures
•Non- Absorbable
Nylon Sutures
Prolene Sutures
Stainless Steel Sutures
Others

Market Breakup by Filament Type
•Monofilament
•Multifilament

Market Breakup by Applications
•Ophthalmic Surgery
•Cardiovascular
•Orthopedic Surgery
•Neurological Surgery
•Others

Market Breakup by End User
•Hospitals
•Clinics
•Ambulatory Surgical Centers
•Emergency Medical Services
•Others

Market Breakup by Region

•North America
United States of America
Canada

•Europe
United Kingdom
Germany
France
Italy
Others

•Asia Pacific
China
Japan
India
ASEAN
Australia
Others

•Latin America
Brazil
Argentina
Mexico
Others

•Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Key Trends in the Surgical Sutures Market
Some key trends of the market are as follows:
•Advancements in suture materials and technologies: The development of new suture materials, such as antibacterial and bioabsorbable sutures, has improved the performance, safety, and patient outcomes of surgical sutures, contributing to market expansion.
•Growing demand for minimally invasive surgical procedures: The increasing preference for minimally invasive surgical procedures, which typically require specialized sutures and wound closure techniques, has driven market growth and innovation.
•Rising awareness about proper wound management: Increasing awareness about the importance of proper wound management, particularly in the prevention of surgical site infections, has led to greater demand for advanced surgical sutures.

Surgical Sutures Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
•CONMED Corporation
•B. Braun Melsungen AG
•Johnson & Johnson Private Limited
•Medtronic
•Boston Scientific Corporation
•3M
•Smith+Nephew
•General Electric
•Integra LifeSciences
•Medline Industries, Inc.
•Zimmer Biomet
•Advanced Medical Solutions Group plc.
•Internacional Farmacéutica S.A. de C.V.
•Stryker
•Mellon Medical B.V.
•Apollo Endosurgery, Inc
•Surgical Specialties Corporation
•DemeTECH Corporation
•Teleflex Incorporated
•Coloplast

Content
Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Surgical Sutures Market Overview
3.1 Global Surgical Sutures Market Historical Value (2016-2022)
3.2 Global Surgical Sutures Market Forecast Value (2023-2031)
4 Global Surgical Sutures Market Landscape
4.1 Global Surgical Sutures Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Surgical Sutures Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Surgical Sutures Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Surgical Sutures Market Segmentation
6.1 Global Surgical Sutures Market, by Product Type
6.1.1 Market Overview
6.1.2 Absorbable
6.1.2.1 Synthetic Suture
6.1.2.1.1 Polyglactin 910 Sutures
6.1.2.1.2 Poliglecaprone 25 Sutures
6.1.2.1.3 Polydioxanone Sutures
6.1.2.1.4 Polyglycolic Acid Sutures
6.1.2.1.5 Other Synthetic Sutures
6.1.3 Non- Absorbable
6.1.3.1 Nylon Sutures
6.1.3.2 Prolene Sutures
6.1.3.3 Stainless Steel Sutures
6.1.3.4 Others
6.2 Global Surgical Sutures Market, by Filament Type
6.2.1 Market Overview
6.2.2 Monofilament
6.2.3 Multifilament
6.3 Global Surgical Sutures Market, by Applications
6.3.1 Market Overview
6.3.2 Ophthalmic Surgery
6.3.3 Cardiovascular
6.3.4 Orthopedic Surgery
6.3.5 Neurological Surgery
6.3.6 Others
6.4 Global Surgical Sutures Market, by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Ambulatory Surgical Centers
6.4.5 Emergency Medical Services
6.4.6 Others
6.5 Global Surgical Sutures by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Surgical Sutures Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Surgical Sutures Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Surgical Sutures Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Surgical Sutures Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Surgical Sutures Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 CONMED Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 B. Braun Melsungen AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Johnson & Johnson Private Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 3M
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Smith+Nephew
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 General Electric
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Integra LifeSciences
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Medline Industries, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Zimmer Biomet
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Advanced Medical Solutions Group plc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Internacional Farmacéutica S.A. de C.V.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Stryker
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Mellon Medical B.V.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Apollo Endosurgery, Inc
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Surgical Specialties Corporation
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 DemeTECH Corporation
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Teleflex Incorporated
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 Coloplast
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
18 Global Surgical Sutures Market-Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark